Novozymes A/S Stock

Novozymes A/S ROCE

The Return on Capital Employed (ROCE) of Novozymes A/S (NSIS B.CO) as of Aug 5, 2026 is 5.90 %. In the previous year, Return on Capital Employed (ROCE) was 31.94 % — a change of -81.54% (lower).

ROCE

5.90 %

YoY

-81.54%

Last updated:

In 2026, Novozymes A/S's return on capital employed (ROCE) was 5.90 %, a -81.54% increase from the 31.94 % ROCE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Novozymes A/S Stock analysis

What does Novozymes A/S do? Novozymes A/S is a leading company in the field of biocatalysis and microbial solutions. It was founded in Denmark in 1925 under the name Nordisk Insulinlaboratorium. In 2000, the company was renamed Novozymes A/S and became part of the globally operating Novo Group. Novozymes' business model is to optimize the use of biocatalysts, enzymes, and microorganisms to offer sustainable solutions for various industries. Biocatalysts are biological molecules that accelerate or enable chemical reactions. The company works closely with customers in agriculture, household, food and beverage, laundry and cleaning products, animal feed, bioenergy, and biopharmaceutical industries. Novozymes' offerings include various divisions. The largest is the enzymes division, which produces enzymes for various industries. Novozymes' enzymes are used in the food and beverage industry, pulp and paper industry, and bioenergy, among others. The microbial solutions division offers various microorganisms that can be used in the production of biogas, animal feed, or odor removal. Novozymes also has a bioagriculture division that develops solutions for sustainable agriculture. This includes disease- and pest-resistant bioseeds, as well as enhanced soil and plant care. The company also has a biopharmaceutical division that focuses on producing enzymes for disease treatment. An important goal of Novozymes is to promote sustainability and environmental protection. The company advocates for the use of renewable resources and energy-efficient processes. This is also reflected in their products, which contribute to optimizing agricultural processes and reducing greenhouse gas emissions, for example. One example of a Novozymes product is NovoGro, a biofertilizer for sustainable agriculture. NovoGro enhances nutrient uptake in plants and contributes to healthy soils. Another product is an enzyme blend called Novozyme 188, which is used in beer production to improve filtration. In summary, Novozymes A/S is a company specializing in biocatalysis and microbial solutions. The company works closely with customers from various industries to offer sustainable solutions and promote environmental protection. Novozymes has different divisions and offers solutions such as enzymes and microorganisms that can be used in the food and beverage industry, pulp and paper industry, bioenergy, biopharmaceuticals, and many other areas. With its commitment to sustainability and environmental protection, Novozymes contributes to shaping a better future. Novozymes A/S is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Novozymes A/S's Return on Capital Employed (ROCE)

Novozymes A/S's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Novozymes A/S's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Novozymes A/S's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Novozymes A/S’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Novozymes A/S stock

Return on Capital Employed (ROCE) of Novozymes A/S is 5.90 % in 2026.

Return on Capital Employed (ROCE) of Novozymes A/S changed from 31.94 % to 5.90 %, representing a -81.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Novozymes A/S since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Novozymes A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Novozymes A/S

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Novozymes A/S